1.Pregnancy outcomes following the administration of high doses of dexamethasone in early pregnancy.
Hasan NAMDAR AHMADABAD ; Sabah KAYVAN JAFARI ; Maryam NEZAFAT FIRIZI ; Ali Reza ABBASPOUR ; Fahime GHAFOORI GHARIB ; Yusef GHOBADI ; Samira GHOLIZADEH
Clinical and Experimental Reproductive Medicine 2016;43(1):15-25
OBJECTIVE: In the present study, we aimed to evaluate the effects of high doses of dexamethasone (DEX) in early pregnancy on pregnancy outcomes. METHODS: Pregnant BALB/c mice were treated with high-dose DEX in the experimental group or saline in the control group on gestational days (GDs) 0.5 to 4.5. Pregnant mice were sacrificed on GDs 7.5, 13.5, or 18.5 and their peripheral blood, placentas, fetuses, and uterine tissue were collected. Decidual and placenta cell supernatants were examined to evaluate the effect of DEX on the proliferation of mononuclear cells, the quantity of uterine macrophages and uterine natural killer (uNK) cells, and levels of progesterone and 17β-estradiol, as determined by an 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide assay, immunohistochemistry, and enzyme-linked immunosorbent assay, respectively. We also were measured fetal and placental growth parameters on GD 18.5. RESULTS: We found that high doses of DEX were associated with an increased abortion rate, enhancement of the immunosuppressive effect of the decidua, alterations in placental growth parameters, decreased progesterone and 17β-estradiol levels, and a reduced frequency of macrophages and uNK cells. CONCLUSION: Our data suggest that the high-dose administration of DEX during early pregnancy negatively affected pregnancy outcomes.
Abortion, Induced
;
Animals
;
Decidua
;
Dexamethasone*
;
Enzyme-Linked Immunosorbent Assay
;
Estradiol
;
Female
;
Fetus
;
Immunohistochemistry
;
Killer Cells, Natural
;
Macrophages
;
Mice
;
Placenta
;
Pregnancy
;
Pregnancy Outcome*
;
Pregnancy*
;
Progesterone
2. Efficacy of combined albendazol and praziquntel and their loaded solid lipid nanoparticles components in chemoprophylaxis of experimental hydatidosis
Ali JELOWDAR ; Abdollah RAFIEI ; Mahmood RAHDAR ; Abdollah RAFIEI ; Mohammad Reza ABBASPOUR ; Iran RASHIDI
Asian Pacific Journal of Tropical Biomedicine 2017;7(6):549-554
Objective To evaluate the efficacy of combined ABZ and PZQ and their solid lipid nanoparticles in chemoprophylaxis of cystic echinococcosis (CE). Methods ABZ and PZQ loaded solid lipid nanoparticles (SLNs) were prepared by high shear homogenization and microemulsion congealing techniques with some minor modification. Nanoparticles average size, polydispersity index (PDI), and particle size distribution were determined by scanning electron microscopy (SEM) and photon correlation spectroscopy. Forty females BALB/c were experimentally infected by protoscoleces (PSC) and randomly divided into four equal groups of 10 mice. After the end of the 3 months treatment period and 2 months rest, mice were sacrificed and the peritoneal cavity was opened for removal, counting, measuring, and histological analysis of hydatid cyst. Results The results indicated that ABZ and PZQ chemoprophylaxis treatment reduced the wet weight and size of developed cysts 77.3% and 79%, respectively. The corresponding result for the ABZ and PZQ loaded SLNs was 83% and 85%, respectively. Conclusions This study for the first time demonstrated that ABZ and PZQ loaded SLNs is superior to free ABZ and PZQ for the chemoprophylaxis of CE in mice.